• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.铂配合物可抑制博来霉素治疗后潜在致死性损伤的修复。
Br J Cancer. 1987 Mar;55(3):245-8. doi: 10.1038/bjc.1987.47.
2
Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatment.铂染料复合物可抑制博来霉素治疗后潜在致死性损伤的修复。
Br J Cancer. 1989 May;59(5):722-6. doi: 10.1038/bjc.1989.152.
3
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).一株对顺二氯二氨铂(II)耐药的人鳞状癌细胞系的特性分析
Cancer Res. 1987 Jan 15;47(2):388-93.
4
Intracellular distribution of a platinum-rhodamine 123 complex in cis-platinum sensitive and resistant human squamous carcinoma cell lines.顺铂敏感和耐药的人鳞状癌细胞系中铂-罗丹明123复合物的细胞内分布
Biochem Pharmacol. 1986 Oct 1;35(19):3365-9. doi: 10.1016/0006-2952(86)90437-5.
5
Repair of potentially lethal damage after single injection or continuous infusion of bleomycin.
Gan. 1978 Apr;69(2):195-9.
6
Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.热疗对人鳞状细胞癌系和顺二氯二氨铂(II)耐药亚系中顺二氯二氨铂(II)(罗丹明123)2[四氯铂(II)]的影响。
Cancer Res. 1988 Sep 15;48(18):5101-5.
7
Chemopotentiation of mitomycin C cytotoxicity in vitro by platinum complexes.铂配合物对丝裂霉素C体外细胞毒性的化学增敏作用。
Br J Cancer. 1985 Dec;52(6):833-9. doi: 10.1038/bjc.1985.266.
8
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.烷化剂:人类细胞系中交叉耐药模式的体外研究
Cancer Res. 1986 Sep;46(9):4379-83.
9
Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.对顺铂敏感和耐药的人鳞状癌细胞系进行联合γ射线照射及随后的顺铂治疗。
Int J Radiat Biol. 2004 Apr;80(4):291-9. doi: 10.1080/09553000410001679767.
10
Electrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: Improved effectiveness of cisplatin in HPV-positive tumors.电化学疗法联合顺铂或博来霉素治疗头颈部鳞状细胞癌:HPV 阳性肿瘤中顺铂疗效的提高。
Bioelectrochemistry. 2018 Oct;123:248-254. doi: 10.1016/j.bioelechem.2018.06.004. Epub 2018 Jun 6.

引用本文的文献

1
Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatment.铂染料复合物可抑制博来霉素治疗后潜在致死性损伤的修复。
Br J Cancer. 1989 May;59(5):722-6. doi: 10.1038/bjc.1989.152.

本文引用的文献

1
Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.从人鳞状细胞癌培养出的需要锚定和成纤维细胞支持的致瘤性角质形成细胞系。
Cancer Res. 1981 May;41(5):1657-63.
2
Cellular repair factors influencing radiocurability of human malignant tumours.影响人类恶性肿瘤放射可治愈性的细胞修复因子
Br J Cancer. 1982 Jan;45(1):10-6. doi: 10.1038/bjc.1982.2.
3
Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy.来自对放疗有已知反应患者的早期传代鳞状细胞癌系的细胞X射线修复参数。
Br J Cancer. 1984 May;49(5):595-601. doi: 10.1038/bjc.1984.94.
4
The role of DNA repair processes in the response of human tumors to fractionated radiotherapy.
Int J Radiat Oncol Biol Phys. 1984 Jul;10(7):1127-34. doi: 10.1016/0360-3016(84)90187-1.
5
Bleomycin--mode of action with particular reference to the cell cycle.
Pharmacol Ther. 1983;23(3):417-41. doi: 10.1016/0163-7258(83)90022-0.
6
Adjuvant chemotherapy in advanced head and neck cancer. An update.晚期头颈癌的辅助化疗。最新进展。
Am J Surg. 1982 Oct;144(4):432-6. doi: 10.1016/0002-9610(82)90417-2.
7
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).顺铂、博来霉素和甲氨蝶呤(PBM)治疗晚期头颈部鳞状细胞癌
Cancer Treat Rep. 1981 Sep-Oct;65(9-10):787-91.
8
Effect of bleomycin-radiotherapy combination in management of head and neck squamous cell carcinoma.博来霉素与放疗联合应用于头颈部鳞状细胞癌治疗的效果
Cancer. 1981 Sep 1;48(5):1106-9. doi: 10.1002/1097-0142(19810901)48:5<1106::aid-cncr2820480510>3.0.co;2-q.
9
The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusions prior to definitive radiotherapy: an RTOG pilot study.在确定性放疗前,采用铂类和博来霉素输注对不可切除的Ⅲ期和Ⅳ期头颈部表皮样癌进行辅助治疗:一项放射肿瘤学组(RTOG)的初步研究。
Cancer. 1980 Nov 1;46(9):1919-24. doi: 10.1002/1097-0142(19801101)46:9<1919::aid-cncr2820460905>3.0.co;2-x.
10
Plateau-phase cultures of mammalian cells: an in vitro model for human cancer.哺乳动物细胞的平台期培养:一种人类癌症的体外模型。
Curr Top Radiat Res Q. 1972 Jul;8(1):39-43.

铂配合物可抑制博来霉素治疗后潜在致死性损伤的修复。

Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.

作者信息

Holden S A, Teicher B A, Boeheim K, Weichselbaum R R, Ervin T J

出版信息

Br J Cancer. 1987 Mar;55(3):245-8. doi: 10.1038/bjc.1987.47.

DOI:10.1038/bjc.1987.47
PMID:2436643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2001757/
Abstract

The SCC-25 cell line is a well-established line derived from a human squamous carcinoma of the head and neck. The capacity of this cell line for recovery from potentially lethal damage following X-ray treatment has been documented. The survival curve of stationary phase SCC-25 cells exposed to various concentrations of bleomycin is biphasic with an initial sensitive phase and a less sensitive second phase as is common for many cell lines. Stationary phase SCC-25 cells were exposed to 100 mU ml-1 of bleomycin for 1 h. The drug was removed and the cells were allowed various periods to recover from potentially lethal damage. After 24 h, the SCC-25 cells showed a recovery ratio (R/R0) of 7.0 which corresponded to an immediate survival at a drug level of 27 mU ml-1, a dose 3.7-fold less than the exposure concentration of 100 mU ml-1. Over the course of the first 4 h following bleomycin exposure, 0.5 microM CDDP was a very effective inhibitor of potentially lethal damage repair, giving a R/R0 of 1.1 or nearly complete inhibition of recovery. Between 2 and 4 h the R/R0 was 1.6-1.8 with CDDP and 4.1-5.3 without CDDP indicating appreciable inhibition of recovery. Plant (10 microM) and Plato (10 microM) produced potentially lethal damage recovery inhibition patterns very similar to that of CDDP. After 1 h the recovery ratios in the presence of Plant and Plato were 1.1-1.3. Between 2 and 4 h, Plato and Plant gave recovery ratios of 1.8-2.3 and 1.6-1.9, respectively. NIPt and Pt(terpy) were examined at both 10 microM and 25 microM for their ability to inhibit potentially lethal damage recovery after bleomycin treatment. After 1 h, NIPt gave a recovery ratio of 1.3-1.4, and after 2-4 h the recovery ratio was 1.7-2.6. Pt(terpy) gave recovery ratios of 1.3-1.6 after 1 h and 1.5-1.8 after 24 h.

摘要

SCC - 25细胞系是一种源自人头部和颈部鳞状癌的成熟细胞系。该细胞系在X射线处理后从潜在致死性损伤中恢复的能力已有文献记载。处于静止期的SCC - 25细胞暴露于不同浓度博来霉素后的存活曲线呈双相,具有初始敏感阶段和较不敏感的第二阶段,这对许多细胞系来说是常见的。将处于静止期的SCC - 25细胞暴露于100 mU/ml的博来霉素中1小时。去除药物后,让细胞在不同时间段从潜在致死性损伤中恢复。24小时后,SCC - 25细胞的恢复率(R/R0)为7.0,这相当于在药物水平为27 mU/ml时的即时存活率,该剂量比100 mU/ml的暴露浓度低3.7倍。在博来霉素暴露后的前4小时内,0.5 microM顺铂是潜在致死性损伤修复的非常有效的抑制剂,恢复率(R/R0)为1.1,即几乎完全抑制恢复。在2至4小时之间,有顺铂时R/R0为1.6 - 1.8,无顺铂时为4.1 - 5.3,表明恢复受到明显抑制。普兰(10 microM)和普拉托(10 microM)产生的潜在致死性损伤恢复抑制模式与顺铂非常相似。1小时后,存在普兰和普拉托时的恢复率为1.1 - 1.3。在2至4小时之间,普拉托和普兰的恢复率分别为1.8 - 2.3和1.6 - 1.9。研究了10 microM和25 microM的NIPt和Pt(terpy)在博来霉素处理后抑制潜在致死性损伤恢复的能力。1小时后,NIPt的恢复率为1.3 - 1.4,2至4小时后的恢复率为1.7 - 2.6。Pt(terpy)在1小时后的恢复率为1.3 - 1.6,24小时后的恢复率为1.5 - 1.8。